N ational health expenditures in the United States reached a total of $2.6 trillion in 2010, more than 10-fold over than the sum spent in 1980. 1 The rate of spending growth has moderated somewhat in recent years, perhaps due to a combination of policy changes and the economic downturn that began in 2008. 2 However, this may be a temporary reprieve before aging demographics begin presenting a challenge to the funding of government health care programs. In recognition of this problem, Congress implemented the Medicare Sustainable Growth Rate in 1998, which compares annual expenditures on physician services to a target and then adjusts the following year's payments accordingly. In theory, the Sustainable Growth Rate has almost always mandated a significant cut in all Medicare payments to physicians (27.4% in 2012) . 3 In practice, Congress has almost always prevented this cut through legislation. However, these annual "doc fixes" only defer the Sustainable Growth Rate cuts to a later date. Due to politics and the magnitude of the budget deficit, any permanent solution to the Sustainable Growth Rate dilemma will likely entail some reduction in payments. However, cutting payments to all physicians indiscriminately would result in punishing some health care providers who did little to contribute to the problem. This would not incentivize best practices in cost containment. Therefore, it makes sense to determine which types of treatment are the biggest drivers of health care spending and investigate their use more closely.
Taken together, musculoskeletal diseases are currently the single most reported category of health problems in the United States. Although rarely lethal, these disorders often cause debilitating pain and chronic disability, resulting in an estimated economic burden of $849 billion, or 7.7% of the US gross domestic product, in 2004. 4 It would seem to follow that orthopedic care would be a key driver of health care spending. However, Alhassani et al 3 investigated spending in excess of the Sustainable Growth Rate targets between 2002 and 2009 and found that, as a specialty, orthopedics contributed to the increase less than internal medicine, cardiology, ophthalmology, diagnostic radiology, and even family practice. An important distinction should be made between the economic burden of a set of diseases and the costs that may be associated with a particular specialty. Studies have demonstrated that orthopedic surgeons are only responsible for approximately 32% of new problem visits for musculoskeletal diseases, with the majority of visits handled by other groups, both physicians and midlevel providers. 5, 6 No studies have yet examined growth in various subsets of orthopedic care or the evolving economic cost of these services. With this in mind, the authors sought to restrict the focus of this study to the effect of care for musculoskeletal diseases provided by orthopedic surgeons. A nationwide database was used to evaluate trends in utilization and reimbursement of all musculoskeletal procedures usually provided by orthopedic surgeons. A secondary purpose of the study was to compare these trends to the overall growth in Medicare spending over the past decade.
Materials and Methods
The Medicare Part B Physician/Supplier Procedure Summary Master Files for the years 2000 through 2010 were analyzed. 7 These files contain information on all payments made on behalf of the Medicare population for outpatient care and physicians' services, including surgical fees. Each file is de-identified and made publicly available by the Centers for Medicaid and Medicare Services (CMS), so this study was exempt from institutional review board approval. During the study period, the number of Medicare beneficiaries increased by 18%, from 39,480,028 to 46,589,141 individuals. 8 Although the median age of this population has barely changed over time (72.8 years in 1966 to 73.0 years in 2005), the prevalence of serious comorbidities has increased markedly. 9, 10 The prevalence of diabetes mellitus increased from 13% in 1997 to 28.7% in 2010. 11, 12 The files are organized by Current Procedural Terminology (CPT) code; surgical procedures designated as musculoskeletal (20000-29999) were identified, and those outside the purview of orthopedics were excluded from consideration. For each of the selected procedures, annual volume and reimbursement were recorded. Modifier codes, which are billed by an assistant or ambulatory surgical center in conjunction with a procedure, were excluded from estimates of procedure volume to avoid double counting. However, these modifiers were included in the calculation of total payment amounts because it was felt they represented part of the overall burden imposed by the procedures.
The procedures were grouped into 12 anatomical or functional groups for multiyear analysis (Table 1) . To accurately capture growth in procedure volumes independent of population growth, utilization rates were calculated per 1000 Medicare beneficiaries. 8 Growth in utilization between 2000 and 2010 is presented as a simple percent change for each group. A more complicated methodology was used for analysis of payment data. Once grouped, payment amounts were standardized to the value of the dollar in 2000, based on the Consumer Price Index. 13 These amounts were then divided by the number of Medicare beneficiaries in each year, resulting in payment per Medicare beneficiary.
Finally, to allow a more accurate representation of annualized growth, compound annual growth rates were calculated for each group using the following formula: [(ending value/ beginning value)^(1/No. of years)]21. The same method was used to calculate compound annual growth rate for overall Medicare spending per beneficiary, as tabulated by CMS. 1 Statistical tests are used to ensure that inferences made based on samples were valid for entire populations. Because this study's results already rep-resent conclusions based on the complete Medicare population, statistical tests were not necessary to confirm them.
results
The results, stratified by functional/ anatomical group and year, are presented numerically in Table 2 . These numbers are the actual volumes and total amounts reimbursed for the included procedures in each year. In 2000, a total of 8,161,693 orthopedic procedures were performed. During each of the following 10 years, this number increased. By 2010, a total of 13,622,899 orthopedic procedures were recorded, an overall increase of 66.9%. Total reimbursement increased from $1.6 billion to $2.6 billion (163.7%). The similar rates of increase indicate that average reimbursement per procedure decreased slightly throughout the decade ($196 to $190) .
Utilization trends in the Medicare population from 2000 to 2010 are shown in Table 3 . These findings present increases in procedure volume, correcting for the growth in the number of beneficiaries. Overall, the utilization rate per 1000 beneficiaries increased steadily, from 206.7 in 2000 to 292.4 in 2010 (141.4%). However, a wide range was noted across procedural groupings, with the highest increases seen in spine (1214.1%) and endoscopy/ arthroscopy (1128.0%) and the lowest increases seen in shoulder (110.1%) and humerus and elbow (14.8%). Utilization rates of hand and finger procedures decreased (29.9%).
The overall growth in orthopedic payments over the past decade has been moderate, especially once inflation and growth in the number of Medicare beneficiaries is taken into account. Figure 1 shows the effects of making these corrections: the unadjusted 4.81% compound annual growth rate in orthopedic payments becomes a 2.33% compound annual growth rate above inflation, and only a 0.65% compound annual growth rate above inflation per beneficiary. The generally steady rate of change is marred by a sharp decrease in 2002. This was the only year to date that Congress failed to act to avert the annual automatic cuts in Medicare reimbursement under the Sustainable Growth Rate, resulting in an immediate 6.9% decline in orthopedic payments.
To isolate payment trends from changes in Medicare enrollment, Figure 2 shows the compound annual growth rates for payments per Medicare beneficiary for each of the 12 functional/anatomical groups, as well as for Medicare spending overall. From 2000 to 2010, orthopedic payments increased at a compound annual growth rate of 0.65% above inflation, well below the Medicare average of 4.67%. Although wide variation was observed among the groups, only 2 subsets of procedures had a growth rate higher than the Medicare average: spine (8.00% compound annual growth rate above inflation), and endoscopy/ arthroscopy (4.93% compound annual growth rate above inflation). Several subsets even had negative growth, including hand and finger (2.86% compound annual growth rate below inflation) and pelvis & hip (3.25% compound annual growth rate below inflation).
discussion
The study data demonstrate that orthopedics has seen consistent growth over the past decade. The overall utilization rate increased 41.4%, and because rates are scaled per 1000 beneficiaries, this trend is independent of the growth in the Medicare population. It should be noted that the general procedure category includes procedural codes that would be difficult to attribute to a single anatomical location or type of procedure. All functional/anatomical subsets, except for hand and finger, saw growth in utilization over the period. However, it is interesting to note the wide variation in this growth. Spinal and endoscopic/arthroscopic procedures stand out with their triple-digit increases in utilization rate. Together, these 2 groups increased their share of total orthopedic payments from 14.7% in 2000 to 25.9% in 2010.
Orthopedic payments increased at a compound annual growth rate of 0.65%, above the overall rate of inflation for the period, as measured by the Consumer Price Index. However, this growth appears modest when considered in context. Increasing at a rate well below that of Medicare expenditures overall during the period (4.67% compound annual growth rate above inflation), orthopedic procedures seem to be an unlikely driver of the overall increases in health expenditures. This echoes the findings of Alhassani et al, 3 who ranked orthopedics as 24th of 37 specialties in contributing to spending in excess of the Sustainable Growth Rate goals from 2002 to 2009. This highlights the importance of considering the effect of orthopedic procedures separate from that of musculoskeletal disease overall. Thorpe et al 14 investi- gated national data and concluded that only 15 medical conditions were responsible for half of the overall growth in health care spending between 1987 and 2000. Three of the conditions highlighted in that studytrauma, arthritis, and back problems-are likely often included in studies reporting the economic effect of musculoskeletal disease. The current findings indicate that a significant portion of treatment of these and other musculoskeletal conditions occurs outside the umbrella of procedures considered here. This study confirms especially rapid growth in surgical interventions of the 15 reported that the annual number of discharges for spinal fusions increased 137% between 1998 and 2008 and that the mean age for fusion patients had increased by 5.4 years. This trend has generated controversy because some argue that spinal fusion is increasingly being performed to treat age-related disk degeneration, an indication for which limited evidence exists. 16, 17 In addition, a 2009 systematic review of 24 trials concluded that fusion was more no effective than intense rehabilitation in treating nonradicular back pain with common degenerative changes. Surgical treatment was also found to have only short-term advantages in the treatment of radiculopathy with disk herniation and symptomatic spinal stenosis. 18 It has been claimed that the increase in spinal fusions must be due to economic incentives on the part of provider. 19 However, others have argued the increase is likely due to a combination of many factors, including an increased supply of fellowship-trained spine specialists, an aging population, and improvements in surgical technique and technology. Surgeons point out that advances in minimally invasive technology, anesthesia, and perioperative care have made spinal procedures far safer. This has opened spinal surgery to many patients who previously would have been excluded due to their comorbidities. 20 The current data show that arthroscopic and endoscopic procedures also experienced exceptional growth over the past decade (compound annual growth rate of 4.93% in payments per beneficiary). These procedures often induce less postoperative pain and allow quicker recovery than traditional open approaches, although long-term outcomes are often similar. 21 Although this coding may be viewed as adding a layer of cost to surgery, arthroscopic and endoscopic procedures tend to lower overall expense by decreasing complications and shortening hospital stays. The cost effectiveness of these procedures has been demonstrated in the literature, including for lumbar fusion, 22 ankle arthrodesis, 23 rotator cuff repair, 24 Bankart repairs of the shoulder, 25 and meniscectomy. 26 Certain limitations are imposed on these results by use of the Medicare Part B database. The database does not breakdown procedure count by provider type. Although the authors attempted to only include codes felt to be primarily used by orthopedic surgeons, it is likely that other providers performed some of the procedures contained in the database. This shortcoming was partially remedied by including only surgical codes, but this is not a perfect fix; orthopedists perform many of the same procedures as podiatrists (foot and ankle) and neurosurgeons (spine). It is also important to emphasize that the database only reports Medicare reimbursements for allowed procedures. As a rule, Medicare only reimburses 80% of what CMS deems to be a procedure's "allowable" charge, and the patient is supposed to provide the remaining 20%. 27 Although the current authors feel that these data provide an important economic perspective, it is not equivalent to a full analysis of economic burden, which would include data from other payers, as well as a consideration of indirect costs.
In most industries, strong growth in revenues is taken as good news, as a sign of strength. This is not always the case in medicine. As well-compensated professionals reimbursed largely on a fee-forservice basis, physicians will find their economic motives under scrutiny as health care budgets are stretched thin. Several points in the data indicate that orthopedic surgeons seem to be doing their part to contain costs in the face of aging demographics and a ballooning patient base. First, the rate of increase in orthopedic payments over the past decade, while significant, tracks well below the rates of increase for both national health expenditures and Medicare payments overall. Second, average reimbursement per procedure has decreased slightly and is more significant once inflation is taken into account. Finally, only 2 subsets of orthopedic payments had growth above the national average for health care expenditures. Nevertheless, exceptional growth attracts attention, so areas of surgery with above-average growth should anticipate pressure to demonstrate the clinical success and cost effectiveness of their techniques.
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